VIGILVESTLibrary
← Library

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL
SEC CIK 1100682Price charts ↗
Writing the earnings story…

Financials

Revenue+1.2% YoY
$995.8M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Net Income-158.3% YoY
-$14.8M
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
EPS (diluted)-160.0% YoY
-$0.3
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Gross Margin
Sep '23Mar '24Jun '24Sep '24Mar '25Jun '25Sep '25Mar '26
Quarter endingRevenueNet incomeEPS
Mar 2026$995.8M-$14.8M-$0.3
Sep 2025$1.00B$54.4M$1.1
Jun 2025$1.03B$52.3M$1.06
Mar 2025$984.2M$25.5M$0.5
Sep 2024$1.01B$69.7M$1.33
Jun 2024$1.03B$94.1M$1.74
Mar 2024$1.01B$73.0M$1.3
Sep 2023$1.03B$87.4M$1.69

Annual revenue

FY21FY22FY23FY24FY25

Source filings

Download the original reports from the SEC. A 10-Q is the quarterly update; a 10-K is the detailed annual report.

Glossary

Revenue
Net income
EPS
Gross margin
Net margin
Fiscal year

Hover any underlined term for its definition.